ANTHRACYCLINE CARDIOTOXICITY: THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXRAZOXANE AND ITS OPEN RING METABOLITE

被引：0
|
作者：
Jirkovska-Vavrova, A. [1 ]
Jirkovsky, E. [2 ]
Stariat, J. [1 ]
Jansova, H. [1 ]
Roh, J. [1 ]
Lencova-Popelova, O. [2 ]
Kovarikova, P. [1 ]
Sterba, M. [2 ]
Simunek, T. [1 ]
机构：
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic
[2] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic
来源：
HEART | 2014年 / 100卷
关键词：
D O I：
10.1136/heartjnl-2014-306916.20
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
020
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Anthracycline cardiotoxicity and its prevention
    Mott, MG
    CHALLENGES AND OPPORTUNITIES IN PEDIATRIC ONCOLOGY, 1997, 824 : 221 - 228
  • [22] Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients
    Elbl, L
    Hrstkova, H
    Tomaskova, I
    Blazek, B
    Michalek, J
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (11) : 678 - 684
  • [23] Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients
    Lubomir Elbl
    Hana Hrstkova
    Iva Tomaskova
    Bohumir Blazek
    Jaroslav Michalek
    European Journal of Pediatrics, 2005, 164 : 678 - 684
  • [24] Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population
    Chen, Bing
    Shi, Hao-Qiang
    Feng, Meihua Rose
    Wang, Xi-Han
    Cao, Xiao-Mei
    Cai, Wei-Min
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [25] Population Pharmacokinetics and Pharmacodynamics of Isoniazid and its Metabolite Acetylisoniazid in Chinese Population
    Chen, Bing
    Shi, Hao-Qiang
    Feng, Meihua Rose
    Wang, Xi-Han
    Cao, Xiao-Mei
    Cai, Wei-Min
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [26] STUDY OF MOLECULAR MECHANISMS INVOLVED IN CARDIOPROTECTIVE ACTION OF DEXRAZOXANE AGAINST ANTHRACYCLINE CARDIOTOXICITY IN RABBITS
    Jirkovsky, E.
    Lencova, O.
    Jirkovska, A.
    Potuckova, E.
    Hroch, M.
    Adamcova, M.
    Simunek, T.
    Gersl, V.
    Sterba, M.
    HEART, 2014, 100
  • [27] EFFECTIVE CARDIOPROTECTION AGAINST ANTHRACYCLINE CARDIOTOXICITY IN ISOLATED CARDIOMYOCYTES AND RABBITS IS BASED ON DEXRAZOXANE INTERACTION WITH TOPOISOMERASE II BETA INSTEAD OF IRON CHELATION BY ITS METABOLITE ADR-925
    Jirkovsky, Eduard
    Jirkovska, Anna
    Bavlovic-Piskackova, Hana
    Skalicka, Veronika
    Pokorna, Zuzana
    Karabanovich, Galina
    Brazdova, Petra
    Lencova-Popelova, Olga
    Mazurova, Yvona
    Adamcova, Michaela
    Roh, Jaroslav
    Sterbova-Kovarikova, Petra
    Simunek, Tomas
    Sterba, Martin
    HEART, 2019, 105 : A67 - A67
  • [28] Anthracycline cardiotoxicity prevention by dexrazoxane: Breakthrough of a barrier - Sharpens antitumor profile and therapeutic index
    Hellmann, K
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 332 - 333
  • [29] Dexrazoxane role in the prevention of anthracycline cardiotoxicity in children with acute leukemia: a meta-analysis
    Sousa, J.
    Puga, L.
    Lopes, J.
    Saleiro, C.
    De Campos, D.
    Gomes, A. R.
    Lourenco, C.
    Goncalves, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 275 - 275
  • [30] Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism
    Cusack, BJ
    Gambliel, H
    Musser, B
    Hadjokas, N
    Shadle, SE
    Charlier, H
    Olson, RD
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (04) : 517 - 526
12345